Circadian variation and triggers of onset of acute cardiovascular disease.

Circulation
J E MullerP H Stone

Abstract

Information obtained during the past decade suggests the need to reexamine the possibility that the onset of myocardial infarction and sudden cardiac death is frequently triggered by daily activities. The importance of physical or mental stress in triggering onset of coronary thrombosis is supported by the findings that 1) the frequencies of onset of myocardial infarction, sudden cardiac death, and stroke show marked circadian variations with parallel increases in the period from 6:00 AM to noon, 2) transient myocardial ischemia shows a similar morning increase, and episodes are often preceded by mental or physical triggers, 3) a ruptured atherosclerotic plaque, often nonobstructive by itself, lies at the base of most coronary thrombi, 4) a number of physiologic processes that could lead to plaque rupture, a hypercoagulable state or coronary vasoconstriction, are accentuated in the morning, and 5) aspirin and beta-adrenergic blocking agents, which block certain of these processes, have been shown to prevent disease onset. The hypothesis is presented that occlusive coronary thrombosis occurs when 1) an atherosclerotic plaque becomes vulnerable to rupture, 2) mental or physical stress causes the plaque to rupture, and 3) increase...Continue Reading

References

Dec 9, 1976·The New England Journal of Medicine·G H MudgeE Braunwald
Apr 15, 1978·Lancet·M W Millar-CraigE B Raftery
May 17, 1979·The New England Journal of Medicine·S Moncada, J R Vane
Mar 1, 1977·The American Journal of Cardiology·S J Schang, C J Pepine
Apr 1, 1989·Stroke; a Journal of Cerebral Circulation·J R MarlerM A Foulkes
Nov 21, 1985·The New England Journal of Medicine·J E MullerT Robertson
Oct 23, 1986·The New England Journal of Medicine·P L LudmerP Ganz
Aug 15, 1988·Annals of Internal Medicine·P F Cohn
Apr 21, 1988·The New England Journal of Medicine·A RozanskiD S Berman
May 1, 1986·The American Journal of Cardiology·J E DeanfieldA P Selwyn
Oct 9, 1986·The New England Journal of Medicine·C T ShermanL Morgenstern
Aug 1, 1987·Circulation·M Fujita, D Franklin
Oct 1, 1987·The American Journal of Cardiology·S N WillichJ E Muller
May 1, 1986·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·L BadimonV Fuster
Aug 15, 1986·The American Journal of Cardiology·A P SelwynH A O'Brien
Jan 1, 1987·Circulation·J E MullerP H Stone
Sep 1, 1985·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·R A AllenE J Brommer
Jun 1, 1985·Journal of the American College of Cardiology·V FusterJ H Chesebro
Sep 18, 1985·The American Journal of Cardiology·P Ganz, R W Alexander
Mar 1, 1985·Journal of the American College of Cardiology·J A AmbroseV Fuster
Feb 1, 1985·International Journal of Cardiology·D R ThompsonP R Marchant
Dec 1, 1985·Neurosurgery·S A TsementzisD G Beevers
Jul 1, 1971·The Journal of Clinical Endocrinology and Metabolism·E D WeitzmanL Hellman
Dec 1, 1973·Biorheology·A M Ehrly, G Jung
Nov 3, 1984·Lancet·J E DeanfieldA P Selwyn

❮ Previous
Next ❯

Citations

Jan 9, 2001·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·A P van Alem, J J Piek
Mar 1, 1997·Annals of Neurology·W J Schwartz
Feb 1, 1993·Clinical Cardiology·Y S Hwang, H W Yen
Mar 1, 1997·Clinical Cardiology·D D BuffS Z Bavli
Oct 1, 1995·Diabetes/metabolism Reviews·V SpalloneG Menzinger
Mar 1, 1993·Journal of Clinical Pharmacology·J SombergS Khosla
Mar 1, 1994·Calcified Tissue International·T M Doherty, R C Detrano
Dec 1, 1995·Cardiovascular Drugs and Therapy·T D RuddyA P Boulet
Jan 1, 1990·European Journal of Clinical Pharmacology·T G Pickering
Oct 12, 2000·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·R E De MeersmanJ A Downey
Dec 1, 1993·Journal of General Internal Medicine·P RuddD Guerrero
Mar 1, 1997·Herzschrittmachertherapie & Elektrophysiologie·C WolpertB Lüderitz
Mar 14, 2012·Pediatric Cardiology·Giorgia GrutterMassimo Stefano Silvetti
Jul 27, 2007·Heart and Vessels·Kyoe TanakaKatsusuke Yano
Sep 10, 2011·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Robert B NicholsAdrian Baranchuk
Jun 21, 2008·European Journal of Applied Physiology·Helen JonesGreg Atkinson
Nov 19, 2008·European Journal of Applied Physiology·Kazue Okamoto-MizunoYasushi Ohshiro
Oct 15, 2009·European Journal of Applied Physiology·Greg AtkinsonPhilip N Ainslie
Feb 16, 2008·Cardiovascular Drugs and Therapy·David J Durgan, Martin E Young
Oct 25, 2008·Cardiovascular Drugs and Therapy·Prediman K Shah
Jun 11, 2005·Heart Failure Reviews·Justine I DaviesAllan D Struthers
Jul 16, 2003·Sleep & Breathing = Schlaf & Atmung·James S J Haight, Per Gisle Djupesland
Mar 20, 2001·Current Atherosclerosis Reports·M NaghaviS W Casscells
Jun 9, 2009·Current Atherosclerosis Reports·Elizabeth Shaw, Geoffrey H Tofler
Nov 5, 2003·Current Hypertension Reports·Martin E Young
Apr 25, 2012·Current Hypertension Reports·Yuichiro Yano, Kazuomi Kario
Apr 16, 2013·Current Hypertension Reports·Guido GrassiGiuseppe Mancia
Sep 12, 2000·Current Hypertension Reports·L PoirierY Lacourciere
May 1, 2011·Cardiovascular Intervention and Therapeutics·Kyoichi MizunoHitoshi Takano
Feb 1, 1994·Physiology & Behavior·B J JanssenW J Rietveld
Apr 1, 1995·Controlled Clinical Trials·M C CohenJ E Muller
Apr 11, 1991·Journal of the American College of Cardiology·J C Perry, A Garson
Sep 1, 1992·Journal of the American College of Cardiology·R M Jacoby, R W Nesto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.